Effect of steroid therapy on postoperative course and survival of patients with thoracic esophageal carcinoma

Esophagus

Volumn 1, Issue 2, 2004, Pages 89-94

  Shimada, Hideaki ^a   Okazumi, Shinnichi ^a   Matsubara, Hisahiro ^a   Nabeya, Yoshihiro ^a   Hayashi, Hideki ^a   Shiratori, Tooru ^a   Aoki, Taio ^a   Shuto, Kiyohiko ^a   Gunji, Yoshio ^a   Ochiai, Takenori ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Esophageal cancer; Morbidity; Steroid therapy; Survival

Indexed keywords

EID: 33748853852     PISSN: 16129059     EISSN: 16129067     Source Type: Journal    
DOI: 10.1007/s10388-004-0014-4     Document Type: Article

References (26)

1. The Japanese Society for Esophageal Diseases. Comprehensive registry of esophageal cancer in Japan (1988-1994) 1st ed. 2000: 25-7.
2. Tachimori Y, Kato H. Diagnosis and surgery of esophageal cancer. Crit Rev Oncol Hematol 1998;28:57-71.
3. Isono K, Ochiai T, Okuyama K, Onoda S. The treatment of lymph node metastasis from esophageal cancer by extensive lymphadenectomy. Jpn J Surg 1990;20:151-7.
4. Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991;48:411-20.
5. Kato H, Watanabe H, Tachimori Y, Iizuka T. Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg 1991;51:931-5.
6. Fujita H, Kakegawa T, Yamana H, Shimada I, Toh Y, Tomita Y, et al. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg 1995;222:654-62.
7. Griffin SM, Shaw IH, Dresner SM. Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy: Risk factors and management. J Am Coll Surg 2002;194:285-97.
8. Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Ann Surg 2001;233:338-44.
9. Katsuta T, Saito T, Shigemitsu Y, Kinoshita T, Shiraishi N, Kitano S. Relation between tumour necrosis factor alpha and interleukin 1beta producing capacity of peripheral monocytes and pulmonary complications following oesophagectomy. Br J Surg 1998;85: 548-53.
10. Shigemitsu Y, Saito T, Kinoshita T, Kobayashi M. Influence of surgical stress on bactericidal activity of neutrophils and complications of infection in patients with esophageal cancer. J Surg Oncol 1992;50:90-7.
11. Kono K, Sekikawa T, Matsumoto Y. Influence of surgical stress on monocytes and complications of infection in patients with esophageal cancer - monocyte HLA-DR antigen expression and respiratory burst capacity. J Surg Res 1995;58:275-80.
12. Fan ST, Lau WY, Yip WC, Poon GP, Yeung C, Lam WK, et al. Prediction of postoperative pulmonary complications in esophagogastric cancer surgery. Br J Surg 1987;74:408-10.
13. Tsujinaka T, Kido Y, Ogawa M, Shiozaki H, Murata A, Kobayashi K, et al. Postoperative hyperbilirubinemia after resection of thoracic esophageal cancer. Am J Gastroenterol 1990;85: 1473-9.
14. Scholz J, Steinhofel U, Durig M, Prause A, Bause HW, Hamper K, et al. Postoperative pulmonary complications in patients with esophageal cancer. Clin Invest 1993;71:294-8.
15. Wang LS, Lin HY, Chang CJ, Fahn HJ, Huang MH, Lin CF. Effects of en bloc esophagectomy on nutritional and immune status in patients with esophageal carcinoma. J Surg Oncol 1998; 67:90-8.
16. Tashiro T, Yamamori H, Takagi K, Hayashi N, Furukawa K, Nitta H, et al. Changes in immune function following surgery for esophageal carcinoma. Nutrition 1999;15:760-6.
17. Sayama J, Shineha R, Yokota K. Control of the excessive reaction after surgery for esophageal carcinoma with preoperative administration of the corticosteroids (in Japanese with English abstract). Jpn J Gastroenterol Surg 1994;27:841-8.
18. Shimada M, Saitoh A, Kano T, Takenaka K, Sugimachi K. The effect of a perioperative steroid pulse on surgical stress in hepatic resection. Int Surg 1996;81:49-51.
19. Matsutani T, Onda M, Sasajima K, Miyashita M. Glucocorticoid attenuates a decrease of antithrombin III following major surgery. J Surg Res 1998;79:158-63.
20. Shimada H, Ochiai T, Okazumi S, Matsubara H, Nabeya Y, Miyazawa Y, et al. Clinical benefits of steroid on the surgical stress in patients with esophageal cancer. Surgery 2000;128:791-8.
21. Sato N, Koeda K, Ikeda K, Kimura Y, Aoki K, Iwaya T, et al. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg 2002;236:184-90.
22. Sobin LH, Wittekind C. International union against cancer: TNM classification of malignant tumors. 5th ed. New York: Wiley-Liss; 1997.
23. Ogawa M. Mechanisms of the development of organ failure following surgical insult: the 'second attack' theory. Clin Intensive Care 1996;7:34-8.
24. Kohase M, Henriksen-Destefano D, Sehgal PB, Vilcek J. Dexamethasone inhibits feedback regulation of the mitogenic activity of tumor necrosis factor, interleukin-1, and epidermal growth factor in human fibroblasts. J Cell Physiol 1987;132:271-8.
25. Yamashita Y, Shimada M, Hamatsu T, Rikimaru T, Tanaka S, Shirabe K, et al. Effects of preoperative steroid administration on surgical stress in hepatic resection. Prospective randomized trial. Arch Surg 2001;136:328-33.
26. Takemura S, Miya K, Takao H, Umemoto T, Saji S. Influence of corticosteroid preperative administration for surgical stress of the esophageal cancer patients during peri- and post-operative periods. Jpn J Gastroenterol Surg 1999;32:1133-41.